Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
06/1999
06/10/1999CA2309347A1 Thrombin inhibitors
06/09/1999EP0920511A1 Expression vectors, cells, and methods for preparing thrombopoietin polypeptides
06/09/1999EP0920509A1 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use
06/09/1999EP0920494A2 Pro-protein converting enzyme
06/09/1999EP0920430A1 Purine derivatives and their use as anti-coagulants
06/09/1999EP0920417A1 Il-8 receptor antagonists
06/09/1999EP0920326A1 Antithrombotic materials and methods
06/09/1999EP0920253A1 Il-8 receptor antagonists
06/09/1999EP0799223B1 Piperidineacetic acid derivatives useful as fibrinogen antagonist agent
06/09/1999EP0751932B1 Vitamin-d amide derivatives
06/09/1999CN1219172A Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
06/09/1999CN1219128A Method of increasing nitric oxide synthesis
06/08/1999CA2089972C Sulfonamidocarboxamides
06/03/1999WO1999027098A2 A-33 related antigens and their pharmacological uses
06/03/1999WO1999026983A1 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions
06/03/1999WO1999026945A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS αvβ3 ANTAGONISTS
06/03/1999WO1999026943A1 Thrombin receptor antagonists
06/03/1999WO1999026926A1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
06/03/1999WO1999026918A1 Biphenylamidine derivatives
06/03/1999WO1999026652A1 Mucosal delivery system comprising lipophilic thrombin inhibitors
06/03/1999WO1999026644A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
06/03/1999CA2311969A1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
06/03/1999CA2310852A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
06/03/1999CA2310775A1 Mucosal delivery system comprising lipophilic thrombin inhibitors
06/03/1999CA2310331A1 Biphenylamidine derivatives
06/03/1999CA2309358A1 A-33 related antigens and their pharmacological uses
06/03/1999CA2309204A1 1,3,4-thiadiazoles and 1,3,4-oxadiazoles as .alpha.v.beta.3 antagonists
06/02/1999EP0918875A1 Novel internal ribosome entry site and vector containing same
06/02/1999EP0918860A2 Tumor necrosis factor-related polypeptide
06/02/1999EP0918794A2 Uses for wnt polypeptides
06/02/1999EP0918792A1 Dipeptide benzamidine as a kininogenase inhibitor
06/02/1999EP0918768A1 Aromatic amidine derivatives useful as selective thrombin inhibitors
06/02/1999EP0757718A4 Methods of use of uncoated gel particles
06/02/1999EP0521873B1 Anticoagulant proteins
06/02/1999CN1218478A Cyclic adhesion inhibitors
06/02/1999CN1218395A Buccal delivery system
06/02/1999CN1217924A Medicine for blood generation and preparing method
06/01/1999US5908843 Thrombosis, antiinflammatory agent, arteriosclerosis, antitumor agents
06/01/1999US5908827 Protein from urine named component B
06/01/1999US5908637 Transmucosal delivery system
06/01/1999US5908625 Administering a genetic engineered protein
05/1999
05/27/1999WO1999025720A1 Carbohydrate derivatives
05/27/1999WO1999025695A1 5-arylpyrazole compounds
05/27/1999WO1999025683A1 Position-4 substituted 2-pyrrolidinone derivatives to reduce the level of extracellular glutamate
05/27/1999WO1999025383A1 Conjugates comprising two active agents
05/27/1999WO1999025367A2 Treatment of hematologic disorders
05/27/1999WO1999025365A1 Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis
05/27/1999WO1999025357A1 USE OF 9-DEOXY-2', 9-α-METHANO-3- OXA-4,5,6- TRINOR-3, 7-(1',3'-INTERPHENYLENE) -13,14-DIHYDRO- PROSTAGLANDIN F1 TO TREAT PERIPHERAL VASCULAR DISEASE
05/27/1999WO1999014346A3 SENSE mRNA THERAPY
05/27/1999WO1999010371A3 Cyclopeptide derivatives as adhesion inhibitors
05/27/1999CA2310319A1 2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level
05/27/1999CA2309919A1 Treatment of hematologic disorders
05/26/1999EP0917572A2 Secreted proteins and polynucleotides encoding them
05/26/1999EP0917539A1 Anticoagulant peptide fragments derived from apolipoprotein b-100
05/26/1999EP0917528A1 New amidino derivatives and their use as thrombin inhibitors
05/26/1999EP0746545B1 Nipecotic acid derivatives as antithrombic compounds
05/26/1999EP0602173B1 Topical fibrinogen complex
05/26/1999CN1217207A Shengxuebao-medicine for improving hematopoitic function
05/26/1999CN1217206A Phytodrug for treatment and management of sickle cell anemia and method of preparing and using same
05/26/1999CN1217195A Zhixuening-medicine for stopping bleeding
05/26/1999CN1217186A Preparation method for medicinal composition containing hydrogenated pyridine derivative as active components
05/25/1999US5907032 Thrombin preparation
05/25/1999US5906984 Treatment of marrow failure states
05/25/1999US5906817 Biocompatible implant for the expression and in vivo secretion of a therapeutic substance
05/25/1999CA2067371C Stable hemoglobin based composition and method to store same
05/20/1999WO1999024583A1 Dna demethylase, therapeutic and diagnostic uses thereof
05/20/1999WO1999024469A1 Secreted proteins and polynucleotides encoding them
05/20/1999WO1999024462A2 Novel conjugates of rgd-containing peptides and endogenous carriers
05/20/1999WO1999024419A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999WO1999024408A1 Heterocyclic compounds having mmp and tnf inhibitory activity
05/20/1999WO1999024399A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999WO1999024076A2 Salicylate derivatized therapeutic and diagnostic agents
05/20/1999WO1999024074A2 Novel conjugates of opioids and endogenous carriers
05/20/1999WO1999024035A1 Benzothiazole protein tyrosine kinase inhibitors
05/20/1999WO1999023996A2 Compositions containing red rice fermentation products, frementation processes and monascus strains therefor
05/20/1999WO1999023967A1 Use of hemoglobin to treat systemic inflammatory response syndrome
05/20/1999WO1999010494A3 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
05/20/1999WO1999008718A3 Bioresorbable compositions for implantable prostheses
05/20/1999CA2309319A1 Benzothiazole protein tyrosine kinase inhibitors
05/20/1999CA2309205A1 Novel conjugates of rgd-containing peptides and endogenous carriers
05/20/1999CA2309007A1 Secreted proteins and polynucleotides encoding them
05/20/1999CA2308361A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999CA2308359A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999CA2308358A1 Heterocyclic compounds having mmp and tnf inhibitory activity
05/19/1999EP0915974A1 Modified tie-2-receptor ligands
05/19/1999EP0915876A1 Tricyclic benzazepine vasopressin antagonists
05/19/1999EP0915651A1 Il-8 receptor antagonists
05/19/1999EP0720599B1 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
05/18/1999CA1340544C Human tissue factor related dna segments, polypeptides and antibodies
05/18/1999CA1340543C Pharmaceutically active compounds
05/14/1999WO1999023076A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
05/14/1999WO1999022734A1 Novel metal complexes
05/14/1999WO1999022733A1 Novel metal complexes
05/14/1999WO1999022732A1 Novel metal complexes
05/14/1999WO1999022721A2 Unsubstituted polydiallylamine for treating hypercholesterolemia
05/14/1999WO1999022609A1 System, method and composition for dialysis and shock treatment
05/14/1999CA2309175A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
05/14/1999CA2308317A1 Novel metal complexes
05/14/1999CA2308316A1 Novel metal complexes
05/14/1999CA2308135A1 Novel metal complexes
1 ... 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 ... 671